IV infusion

DRUG4 trials

Sponsors

Mansoura University, PepGen Inc, Merck Sharp & Dohme (MSD), MERCK SHARP & DOHME PERU S.R.L.,

Conditions

Duchenne Muscular Dystrophy (DMD)ES-SCLC small cell lung cancerMagnesium Infusion in Post-spinal Opioid Pruritis

Phase 2

A Study of PGN-EDO51 or Placebo in People With Duchenne Muscular Dystrophy Amenable to Exon 51-Skipping Treatment

WithdrawnNCT06833931

PepGen IncDuchenne Muscular Dystrophy (DMD)

Start: 2024-12-17End: 2025-05-28Updated: 2025-06-24

Phase 3

A Phase 3, Randomized, Double-Blind Study of MK-7684A in Combination with Etoposide and Platinum Followed by MK-7684A vs Atezolizumab in Combination with Etoposide and Platinum Followed by Atezolizumab for the First-Line Treatment of Participants with Extensive-Stage Small Cell Lung Cancer

RecruitingNL-OMON53681

Merck Sharp & Dohme (MSD)ES-SCLC small cell lung cancer

Start: 2022-06-21Target: 28Updated: 2024-09-16

Unknown Phase

A PHASE II CLINICAL TRIAL OF PEMBROLIZUMAB AS MONOTHERAPY AND IN COMBINATION WITH CISPLATIN+5-FLUOROURACIL IN SUBJECTS WITH RECURRENT OR METASTATIC GASTRIC OR GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA (KEYNOTE-059)

Active, not recruitingPER-017-15

MERCK SHARP & DOHME PERU S.R.L.,

Start: 2015-09-30Target: 12Updated: 2023-09-04

Effect of Intravenous Magnesium on Post-spinal Fentanyl Induced Pruritus Incidence

Mansoura UniversityMagnesium Infusion in Post-spinal Opioid Pruritis

Start: 2020-09-02End: 2021-03-30Target: 144Updated: 2020-09-04